Simple Sell Setup with a interesting Risk Ratio ( > 1:3 ). Details below or on chart:
FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------
- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================
MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------
- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$
TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)
...Thank you for your support and trade with care!
FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------
- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================
MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------
- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$
TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)
...Thank you for your support and trade with care!
Not
...pending orderNot
Rebound in play... follow our idea!Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.
